Bengaluru-based biopharmaceutical major Biocon reported a consolidated net profit of Rs 143.8 crore for the third quarter of 2025–26 (Q3FY26), a rise from a low base of Rs 25.1 crore in the same ...
Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...
Stat reports that at least 18 brand-name drugs on TrumpRx are available in generic form for cheaper through GoodRx or Cost Plus Drugs. Plus: Democratic Sen. Ron Wyden of Oregon called TrumpRx "nothing ...
President Trump on Thursday unveiled his lower-cost drug platform TrumpRx, touting it as “one of the most transformative health care initiatives of all time.” “This launch represents the largest ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. Emory is the data editor at ...
CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...
Swiss pharma giant Novartis AG NVS reported fourth-quarter core earnings per share (excluding one-time charges) of $2.03, which beat the Zacks Consensus Estimate of $1.99. The figure was also up from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results